CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
Chicago, Illinois, United States and 158 other locations
The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...
Phase 3
Melrose Park, Illinois, United States and 19 other locations
condition that puts them at increased risk for severe outcomes of COVID-19 and who have been previously vaccinated with a COVID...
Phase 4
Melrose Park, Illinois, United States and 19 other locations
Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of STRI Formula in Non-Hospitalized Participants with COVID...
Phase 2
Oak Forest, Illinois, United States and 12 other locations
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Chicago, Illinois, United States and 144 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Chicago, Illinois, United States and 28 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Chicago, Illinois, United States and 227 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Evanston, Illinois, United States and 262 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
Chicago, Illinois, United States and 74 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
Melrose Park, Illinois, United States and 149 other locations
Clinical trials
Research sites
Resources
Legal